23 results
10-K
2020 FY
ONCR
Oncorus, Inc.
10 Mar 21
Annual report
4:12pm
significantly harm our reputation and business prospects.
Serious adverse events, undesirable side effects or other unexpected properties of our current … ;
we could be sued and held liable for harm caused to patients; and
our reputation may suffer.
If any of our product candidates are associated
424B4
ONCR
Oncorus, Inc.
12 Feb 21
Prospectus supplement with pricing info
4:23pm
interim or preliminary or topline data and final data could significantly harm our reputation and business prospects.
Serious adverse events, undesirable … outlining the risks of such side effects for distribution to patients;
we could be sued and held liable for harm caused to patients; and
our reputation may
DRS
d4o01uqw 5kvilz5
28 Jan 21
Draft registration statement
12:00am
DRS
EX-10.21
257i6zd
28 Jan 21
Draft registration statement
12:00am
10-Q
c173apk3
12 Nov 20
Quarterly report
8:01am
424B4
t6j sicy2
2 Oct 20
Prospectus supplement with pricing info
12:00am
S-1
EX-10.19
4ytchddljq8e2i60el
11 Sep 20
IPO registration
4:49pm
S-1
kkon5j nx5e
11 Sep 20
IPO registration
4:49pm
S-1
EX-10.10
3s2zkqjytbwybhug3
11 Sep 20
IPO registration
4:49pm
S-1
EX-10.16
ykof8rq st8
11 Sep 20
IPO registration
4:49pm
DRS/A
vbquv4veesjg06
26 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
3r23gq 0u9lauqg
29 Jul 20
Draft registration statement (amended)
12:00am
DRS/A
n5g6 c85s
20 Dec 19
Draft registration statement (amended)
12:00am
DRS/A
EX-10.19
msigrtrv ac
20 Dec 19
Draft registration statement (amended)
12:00am
DRS
EX-10.9
fvs0x 3k5qoxya5pi
31 Oct 19
Draft registration statement
12:00am